We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream

By LabMedica International staff writers
Posted on 28 Feb 2025

Bacteremia, also known as blood poisoning, occurs when bacteria manage to overcome the body's immune defenses. This condition can progress into sepsis, a serious illness that is responsible for over a third of hospital-related deaths each year. While individuals are frequently exposed to bacteria from the environment, they often fight off these infections without experiencing this deadly progression. Scientists are working to understand how bacteria spread throughout the body to cause systemic infections, with the ultimate goal of halting this process before it escalates.

Researchers at U-M Medical School (Ann Arbor, MI, USA) have been investigating this issue, focusing on gram-negative bacteria such as Klebsiella pneumoniae, a common cause of pneumonia-related bacteremia. In their previous studies, they identified three stages in the spread of bacteria: initial infection at a site like the lungs, entry into the bloodstream, and replication while avoiding filtration by the liver and spleen. Traditionally, bacterial infections are analyzed by culturing tissue and counting the resulting bacteria. While it’s easy to measure the initial infection phase by observing how bacteria invade the lungs, and similarly, the third phase by assessing how bacteria survive in the liver and spleen, the transition from the lungs into the bloodstream has been difficult to track.

Using an innovative barcoding system, the researchers labeled bacteria with short DNA sequences in mouse models and employed computer analysis to track the movement of K. pneumoniae throughout the body. They initially hypothesized that the bacteria would replicate in the lungs until they overwhelmed the local immune defenses, eventually spilling into the bloodstream. This type of spread, which they called metastatic dissemination, was observed in some mice. However, they also uncovered an unexpected pattern. About half of the mice showed this metastatic pattern, while the other half exhibited a form of bacterial spread where the bacteria entered the bloodstream on their own without first replicating in large numbers, a process they termed direct dissemination.

The findings, published in Nature Communications, revealed that the metastatic pathway was associated with a more severe infection compared to the direct dissemination route. Moreover, over time, the infection tended to follow the metastatic pattern. The discovery of the direct route suggests that bacteria might be establishing low-level reservoirs in other parts of the body, which could offer new targets for treating blood infections. Additionally, the researchers introduced mutations in both the K. pneumoniae bacteria and the mice, which affected the mode of bacterial dissemination. This hinted that the interaction between the bacteria and the host’s immune system could play a key role in determining the course of the infection.

“The project began with a very basic question—how does bacteria leave the lungs—that we have now provided some insight into, closing a significant gap in our knowledge,” said Michael Bachman, M.D., Ph.D., clinical associate professor of pathology and microbiology and immunology at U-M Medical School.

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Centrifuge
Hematocrit Centrifuge 7511M4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.